This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Clinical Trials
GTTELESCOPE
A Study to Genetically Define Subjects With Geographic Atrophy Secondary to Age-Related Macular Degeneration. TELESCOPE is a community-based genetic screening study designed to identify people with Geographic Atrophy (GA), secondary to Age-related Macular Degeneration (AMD) who have a certain genetic profile.
Overview
In the study, a person’s genetic profile is determined through a process called “genotyping” using saliva samples provided by the potential participants.
Genotyping is a process whereby a person’s DNA is evaluated using biological tests to determine differences in their genetic makeup, when compared to other individuals. A certain genetic makeup might indicate a predisposition to a disease like dry AMD.
The results of the saliva test may qualify participants for enrolment into one of Gyroscope’s ongoing trials evaluating a gene therapy for GA.
- Principal Investigator
Associate Professor Zhichao Wu
In the study, a person’s genetic profile is determined through a process called “genotyping” using saliva samples provided by the potential participants.
Genotyping is a process whereby a person’s DNA is evaluated using biological tests to determine differences in their genetic makeup, when compared to other individuals. A certain genetic makeup might indicate a predisposition to a disease like dry AMD.
The results of the saliva test may qualify participants for enrolment into one of Gyroscope’s ongoing trials evaluating a gene therapy for GA.
- Principal Investigator